Annual Meeting
Date
June 21, 2023
Time
9:00 AM ET
Virtual Meeting
Note: You must register to be eligible to participate in the meeting.
Please vote your proxy online now using the following link, or by telephone
at 866-307-4662.
Date
June 21, 2023
Time
9:00 AM ET
Virtual Meeting
Note: You must register to be eligible to participate in the meeting.
Foghorn Therapeutics is a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression. These medicines are designed to modulate the chromatin regulatory system, which functions to orchestrate the genes our cells express — as well as when, where, and in what order.
Using our Gene Traffic Control® proprietary platform, we are rapidly advancing over 15 programs across a wide range of cancers — and aim to explore treatments for other diseases. Our two lead product candidates are currently in clinical development.
